IDS Capital is the investment arm of a single family office with its roots in the chemical and biopharmaceutical sectors. We focus on investment solutions and opportunities, with a multi-asset orientation, and through a diverse array of fundamental and quantitative strategies deployed by selected specialists worldwide. The primary investment objective is to achieve attractive returns, while seeking to control the risk associated with specific investments.